Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
337
-
Total 13F shares, excl. options
-
88.6M
-
Shares change
-
-3.09M
-
Total reported value, excl. options
-
$10.9B
-
Value change
-
-$352M
-
Put/Call ratio
-
1.42
-
Number of buys
-
178
-
Number of sells
-
-129
-
Price
-
$122.95
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2018
388 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2018.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 337 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88.6M shares
of 99.6M outstanding shares and own 88.97% of the company stock.
Largest 10 shareholders include FMR LLC (13.5M shares), Vanguard Group Inc (7.77M shares), JANUS HENDERSON GROUP PLC (7.16M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.89M shares), BlackRock Inc. (5.1M shares), PERCEPTIVE ADVISORS LLC (4.78M shares), BB BIOTECH AG (3.16M shares), Invesco Ltd. (2.13M shares), FRANKLIN RESOURCES INC (1.84M shares), and Artisan Partners Limited Partnership (1.84M shares).
This table shows the top 337 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.